Advertisement
CNMD vs SCL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Buy and SCL is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNMD’s FA Score shows that 0 FA rating(s) are green whileSCL’s FA Score has 0 green FA rating(s).
- CNMD’s FA Score: 0 green, 5 red.
- SCL’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNMD’s TA Score shows that 4 TA indicator(s) are bullish while SCL’s TA Score has 4 bullish TA indicator(s).
- CNMD’s TA Score: 4 bullish, 6 bearish.
- SCL’s TA Score: 4 bullish, 4 bearish.
Price Growth
CNMD (@Medical Specialties) experienced а -6.96% price change this week, while SCL (@Chemicals: Specialty) price change was -4.43% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -0.32%. For the same industry, the average monthly price growth was +3.43%, and the average quarterly price growth was +2.39%.
Reported Earning Dates
CNMD is expected to report earnings on Oct 22, 2025.
SCL is expected to report earnings on Oct 15, 2025.
Industries' Descriptions
@Medical Specialties (-1.00% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Chemicals: Specialty (-0.32% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
| CNMD | SCL | CNMD / SCL | |
| Capitalization | 2.43B | 1.99B | 122% |
| EBITDA | 192M | 170M | 113% |
| Gain YTD | -28.191 | -11.403 | 247% |
| P/E Ratio | 38.71 | 50.52 | 77% |
| Revenue | 1.25B | 2.33B | 54% |
| Total Cash | 24.3M | 130M | 19% |
| Total Debt | 974M | 712M | 137% |
CNMD | SCL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 3 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 64 | 54 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNMD's Valuation (50) in the Medical Specialties industry is in the same range as SCL (50) in the Chemicals Specialty industry. This means that CNMD’s stock grew similarly to SCL’s over the last 12 months.
CNMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SCL (100) in the Chemicals Specialty industry. This means that CNMD’s stock grew similarly to SCL’s over the last 12 months.
CNMD's SMR Rating (100) in the Medical Specialties industry is in the same range as SCL (100) in the Chemicals Specialty industry. This means that CNMD’s stock grew similarly to SCL’s over the last 12 months.
SCL's Price Growth Rating (54) in the Chemicals Specialty industry is in the same range as CNMD (64) in the Medical Specialties industry. This means that SCL’s stock grew similarly to CNMD’s over the last 12 months.
SCL's P/E Growth Rating (100) in the Chemicals Specialty industry is in the same range as CNMD (100) in the Medical Specialties industry. This means that SCL’s stock grew similarly to CNMD’s over the last 12 months.
| CNMD | SCL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 73% | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 68% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 58% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 36% |
| TrendWeek ODDS (%) | 1 day ago 75% | 1 day ago 64% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 49% |
| Advances ODDS (%) | 6 days ago 73% | 6 days ago 53% |
| Declines ODDS (%) | 1 day ago 77% | 1 day ago 65% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 76% | 1 day ago 44% |
Advertisement
CNMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To CNMD | 1D Price Change % | ||
|---|---|---|---|---|
| CNMD | 100% | -2.52% | ||
| NVST - CNMD | 51% Loosely correlated | -1.10% | ||
| SHC - CNMD | 47% Loosely correlated | -1.98% | ||
| RVTY - CNMD | 47% Loosely correlated | -2.61% | ||
| MYGN - CNMD | 45% Loosely correlated | -4.21% | ||
| A - CNMD | 44% Loosely correlated | -5.95% | ||
More | ||||